deltatrials
Completed PHASE3 INTERVENTIONAL NCT00182403

Fixed Dose Heparin Study

Fixed Dose Unfractionated Heparin for Initial Treatment of Venous Thromboembolism

Sponsor: Heart and Stroke Foundation of Ontario

Conditions Deep Vein Thrombosis Pulmonary Embolism Venous Thromboembolism
Interventions UFH 250 U/kg or LMWH 100 U/kg sc twice daily
Updated 7 times since 2017 Last updated: Jun 6, 2017 Started: Sep 30, 1998 Completion: May 31, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Deep Vein Thrombosis and Pulmonary Embolism and is currently completed. Heart and Stroke Foundation of Ontario leads this study, which shows 7 recorded versions since 1998 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshotCompleted~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Jun 2017 — Jun 2018 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2017 [monthly]

    Completed PHASE3

    First recorded

Sep 1998

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Heart and Stroke Foundation of Ontario
  • McMaster University
Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations